No. No exosome product holds a medicines licence or regulatory approval for aesthetic use in the UK (or elsewhere), so exosomes are used topically as cosmetics rather than injected as medicines. Treat any course promising injectable exosome training with real caution, and check your insurer’s position before offering them in any form.
Exosomes are one of 2026’s most hyped regenerative ingredients, and the hype has outrun the regulation. As of July 2026 no exosome product has regulatory approval for aesthetic use, a point even the enthusiastic trade coverage concedes. In the UK that leaves topical cosmetic use, and it leaves injectable use in territory your insurer is unlikely to follow you into.
The pattern to watch is training providers selling “exosome masterclasses” that quietly skip the regulatory status. The questions that cut through: is the product being used within its licence or notification, will your insurer confirm cover in writing, and what does the evidence actually show beyond manufacturer studies? Polynucleotides sit on firmer ground (licensed devices, growing evidence base) and our regenerative training guide covers the distinction honestly.